Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Stomach (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 3.6 (3.6, 3.7) N/A 13,972 57.1
Alaska 6 4.8 (4.0, 5.6) 1 (1, 15) 35 66.8
New York 3 4.7 (4.6, 4.8) 2 (1, 3) 1,119 54.8
California 3 4.4 (4.3, 4.5) 3 (2, 7) 1,884 60.1
Hawaii 3 4.3 (3.9, 4.8) 4 (1, 14) 80 53.1
New Jersey 3 4.3 (4.1, 4.5) 5 (2, 9) 471 54.8
Connecticut 3 4.3 (4.0, 4.5) 6 (2, 11) 197 58.9
Illinois 3 4.2 (4.1, 4.4) 7 (2, 9) 633 59.1
Massachusetts 3 4.0 (3.8, 4.2) 8 (5, 14) 334 61.1
Louisiana 3 3.8 (3.6, 4.1) 9 (6, 21) 212 57.4
Mississippi 6 3.8 (3.5, 4.1) 10 (5, 25) 135 57.4
Rhode Island 6 3.8 (3.3, 4.3) 11 (2, 36) 51 54.9
Wisconsin 6 3.7 (3.5, 3.9) 12 (8, 23) 272 62.0
Delaware 6 3.7 (3.2, 4.2) 13 (3, 41) 46 57.6
Pennsylvania 6 3.7 (3.5, 3.8) 14 (9, 22) 627 61.3
Texas 3 3.6 (3.5, 3.7) 15 (10, 23) 1,020 55.4
South Carolina 6 3.6 (3.4, 3.8) 16 (9, 30) 229 56.6
North Carolina 6 3.6 (3.4, 3.7) 17 (10, 26) 442 56.4
Georgia 3 3.6 (3.4, 3.7) 18 (10, 27) 405 57.0
Maryland 6 3.6 (3.4, 3.8) 19 (9, 30) 254 51.7
District of Columbia 6 3.5 (2.9, 4.2) 20 (3, 49) 24 46.7
Arkansas 6 3.5 (3.2, 3.7) 21 (10, 39) 129 53.1
Kentucky 3 3.4 (3.1, 3.6) 22 (12, 39) 184 52.7
Indiana 6 3.4 (3.2, 3.5) 23 (15, 37) 266 58.1
Virginia 6 3.3 (3.2, 3.5) 24 (16, 37) 329 57.1
New Mexico 3 3.3 (3.0, 3.7) 25 (10, 45) 85 51.6
Montana 6 3.3 (2.9, 3.8) 26 (7, 49) 45 65.6
Florida 6 3.3 (3.2, 3.4) 27 (19, 36) 961 56.1
Michigan 6 3.3 (3.2, 3.4) 28 (18, 38) 415 57.0
Missouri 6 3.3 (3.1, 3.5) 29 (17, 41) 247 61.1
Alabama 6 3.3 (3.1, 3.5) 30 (16, 43) 201 49.4
Ohio 6 3.3 (3.1, 3.4) 31 (20, 39) 477 55.1
Vermont 6 3.2 (2.7, 3.8) 32 (7, 50) 28 59.5
Washington 5 3.2 (3.1, 3.4) 33 (19, 42) 279 60.3
Colorado 6 3.1 (2.9, 3.3) 34 (22, 46) 191 60.1
Maine 6 3.1 (2.7, 3.5) 35 (14, 49) 62 56.2
Minnesota 6 3.1 (2.9, 3.3) 36 (23, 47) 205 57.6
North Dakota 6 3.0 (2.5, 3.6) 37 (9, 50) 26 58.5
Nebraska 6 3.0 (2.7, 3.4) 38 (17, 49) 68 57.2
Idaho 3 3.0 (2.7, 3.4) 39 (17, 50) 60 61.7
Oregon 6 3.0 (2.8, 3.2) 40 (24, 49) 155 60.4
Tennessee 6 3.0 (2.8, 3.1) 41 (29, 48) 241 52.6
Oklahoma 6 3.0 (2.7, 3.2) 42 (26, 49) 133 53.6
Iowa 3 2.9 (2.7, 3.2) 43 (27, 50) 113 61.4
Kansas 6 2.9 (2.7, 3.2) 44 (25, 50) 100 57.5
Utah 3 2.9 (2.6, 3.2) 45 (23, 50) 78 63.7
West Virginia 6 2.9 (2.6, 3.2) 46 (26, 50) 75 53.7
New Hampshire 6 2.8 (2.4, 3.2) 47 (24, 50) 50 50.8
Arizona 6 2.7 (2.6, 2.9) 48 (38, 50) 236 51.8
South Dakota 6 2.7 (2.2, 3.2) 49 (20, 50) 28 58.6
Wyoming 6 2.3 (1.8, 2.9) 50 (31, 50) 16 52.6
Nevada 6
data not available
N/A
data not available
data not available
Puerto Rico 6 3.2 (3.0, 3.5) N/A 135 44.4
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2022 8:02 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada, Puerto Rico

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top